MarketWatch: Cancer
Pages: 32
Publisher: Datamonitor
Date Published: July 2006
Format: PDF
Price: $200
Overview
Datamonitor’s Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventures, and regulatory decisions.
Table of Contents
In this month’s MarketWatch…
This month’s highlights
Page 2 – Key Announcements
Page 2 – Cancer News Round-up
Female Cancers News
Page 4 – Opinion
Page 5 – News Headlines
Page 4 – Breast Cancer Update
Page 6 – Other Female Cancers Update
Lymphoma and Leukemia News
Page 9 – News Headlines
Page 9 – Lymphoma Update
Page 11 – Leukemia Update
Other Cancers News
Page 13 – Opinion
Page 15 – News Headlines
Page 15 – Colon Cancer Update
Page 16 – Lung Cancer Update
Page 18 – Prostate Cancer Update
Feature Analysis
Page 19 – EntreMed hoping for success with Panzem/Avastin combo
Page 20 – Cell Therapeutics’ Xyotax holds much promise for few patients
Company Spotlight
Page 23 – Pfizer, Inc.
Index
Page 31 – Pharma companies
Page 31 – Biotech companies
Page 32 – Key drugs
